about
Benign convulsion with mild gastroenteritis.Does type I truly dominate hepatic glycogen storage diseases in Korea?: a single center studyDevelopment of multifocal nodular lesions of a liver mimicking hepatic metastasis, following resection of an insulinoma in a child.Alagille Syndrome Candidates for Liver Transplantation: Differentiation from End-Stage Biliary Atresia Using Preoperative CT.PHKA2 mutation spectrum in Korean patients with glycogen storage disease type IX: prevalence of deletion mutations.Epileptic nystagmus and vertigo associated with bilateral temporal and frontal lobe epilepsy.Clinical Use of Measuring Trough Levels and Antibodies against Infliximab in Patients with Pediatric Inflammatory Bowel DiseaseClinical course of infliximab treatment in korean pediatric ulcerative colitis patients: a single center experience.Infliximab "Top-Down" Strategy is Superior to "Step-Up" in Maintaining Long-Term Remission in the Treatment of Pediatric Crohn Disease.Peripheral facial palsy, the only presentation of a primitive neuroectodermal tumor of the skull base.NUDT15 genotype distributions in the Korean population.Mucosal Healing in Paediatric Patients with Moderate-to-Severe Luminal Crohn's Disease Under Combined Immunosuppression: Escalation versus Early Treatment.Complete occlusion of the right middle cerebral artery associated with Mycoplasma pneumoniae pneumonia.Acute Necrotizing Pancreatitis Associated with Mycoplasma pneumoniae Infection in a Child.Impact of Genetic Polymorphisms on 6-Thioguanine Nucleotide Levels and Toxicity in Pediatric Patients with IBD Treated with Azathioprine.Baseline Wall Thickness Is Lower in Mucosa-Healed Segments 1 Year After Infliximab in Pediatric Crohn Disease Patients.Successful azathioprine treatment with metabolite monitoring in a pediatric inflammatory bowel disease patient homozygous for TPMT*3C.Outcome of Alagille Syndrome Patients Who Had Previously Received Kasai Operation during Infancy: A Single Center StudyAdalimumab Treatment in Pediatric-Onset Crohn's Disease Patients after Infliximab Failure: A Single Center Study.Adverse events associated with azathioprine treatment in korean pediatric inflammatory bowel disease patients.Antiviral Efficacy of Tenofovir Monotherapy in Children with Nucleos(t)ide-naive Chronic Hepatitis B.Relationship between azathioprine dosage, 6-thioguanine nucleotide levels, and therapeutic response in pediatric patients with IBD treated with azathioprine.Characteristics and Incidence Trends for Pediatric Inflammatory Bowel Disease in Daegu-Kyungpook Province in Korea: a Multi-Center Study.Author's ResponseComplete sequence-based screening of TPMT variants in the Korean populationSafe azathioprine treatment in a pediatric ulcerative colitis patient with TPMT*16 by thiopurine metabolite monitoringCan proton pump inhibitors cause intestinal inflammation in children?Propionic Acidemia with Novel Mutation Presenting as Recurrent Pancreatitis in a ChildKorean Children and Adolescents with Crohn's Disease Are More Likely to Present with Perianal Fistulizing Disease at Diagnosis Compared to Their European CounterpartsDevelopment and Validation of the Mucosal Inflammation Noninvasive Index For Pediatric Crohn's DiseasePotential Utility of Therapeutic Drug Monitoring of Adalimumab in Predicting Short-Term Mucosal Healing and Histologic Remission in Pediatric Crohn's Disease PatientsPrevention of thiopurine-induced early leukopenia in a Korean pediatric patient with Crohn's disease who turned out to possess homozygous mutations in NUDT15 R139CNationwide Multicenter Study of Eosinophilic Esophagitis in Korean Children
P50
Q34022925-D4BDC448-34BC-4B23-A1D3-E72F5E474BE5Q34923585-5053C1DC-F713-4FF8-9B49-871CB4F5C1EEQ35171735-DCF31474-4E3A-4AFD-BE28-B52116ED5328Q35931486-BFA5D34E-DC40-40BC-B9F3-04BF79F30269Q35996662-3DF207A1-DD27-4015-86F8-331CC38CD483Q37393492-8E289F48-91B0-4292-BBC2-7859E6CE7C1DQ37573910-861A1BDC-B101-4098-A6FC-FF9661F7EF85Q37709063-EF6D1E82-15EF-4593-9165-9DCD1A42F970Q38309652-AA651CDD-656A-44B6-8214-161B43B1183AQ38520418-571D2E7E-CC5D-418F-9E23-B2BA5134B6A6Q38748257-50A8544F-7CD7-405C-B852-FC5074E1FBCDQ38804108-0C2C3DC2-1786-4A30-B89F-84D16936A206Q40105573-697C9A98-9C66-41BF-820D-3C0CE575B90FQ40134975-2AF1AF34-760A-4EF1-8F3F-632BA25555D4Q40582133-5ED48B4C-7377-4E51-8FF9-51479EA3B523Q40815447-78FAECEC-8DA1-4D7F-973B-9696D90E476DQ41787293-8DB10850-3C15-4D1B-BE4D-FC3AB0272A55Q42198737-A0B5923F-8FAE-400E-9A78-396A526F5F8AQ42424792-EC99DC00-3729-4F84-93A2-78C1CC4FAA74Q42919311-CE29ABDF-FA43-4350-91E9-D0B8A5EEC126Q47568387-A61F2D8F-3E2A-4917-A34F-223326FFB08DQ50448602-C9A5C165-3C7E-40B0-8330-A90C323EE1CFQ55286763-FFD0F1C8-98F1-4D5E-83EA-156433EC88A6Q85469386-847A9142-96B2-43B5-995C-1704E6B41B12Q86485715-FD93D0F6-6E0D-4858-B60D-DDD20F4ACF1CQ87410783-0C053DCF-3FE8-4601-AB6A-56438A65411EQ90776378-A6223440-2D19-40D1-896A-751311FD49F6Q91748082-0AD025DD-DF78-4312-91C5-22E9D549D004Q92982391-C87A6300-2286-4898-B548-75FF92465431Q93071951-A22D5823-0BD8-4270-B925-EF64AB226E60Q93203338-9843A6B1-77BA-4F37-A87A-D405BAAF411AQ95302786-80D107DC-7D73-4AE0-B8EA-92327D62E2C5Q96129215-14BC15D5-23B6-4B7C-9B11-5938F738A811
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ben Kang
@ast
Ben Kang
@en
Ben Kang
@es
Ben Kang
@nl
Ben Kang
@sl
type
label
Ben Kang
@ast
Ben Kang
@en
Ben Kang
@es
Ben Kang
@nl
Ben Kang
@sl
prefLabel
Ben Kang
@ast
Ben Kang
@en
Ben Kang
@es
Ben Kang
@nl
Ben Kang
@sl
P106
P1153
55662179600
P21
P31
P496
0000-0002-8516-9803